TipsOfPips
I give this a 40% chance of success. FTSE clearly in a daily and weekly uptrend after a lengthy consolidation. A range has been created and I think the market takes out the low of the range before heading higher. 4H is technically bearish but the market did close inside the last 4H supply which is indicative of a continuation higher to take out the Jan 24 highs.
Expecting the sell off to continue if the market moves up to the supply zone (imbalance) in the manner shown. I classify the trade with a 50% probability of success.
3R Trade Very high probability. 70% chance of success. Wedge pattern into support + higher time frame test of ascending trendline.
Expecting a continuation of the trend here. Had a nice larger consolidation pattern on the higher time frame (it’s over to the left, not directly visible here). The visible pattern here is a 4H pattern and I see it as a reaccumulation pattern above support. The target is a 1:1 measured leg of the weekly trend. Very high probability trade - 60% chance of success.
I like the look of this company on a technical basis. Please see my previous post on this company for more information about the technicals.
Expecting a move up to the red supply zone. Approx target 100, but being conservative by going shy of that. There is strong confluence with other biotech companies here with many others also looking bullish for the following weeks.
Green, Pink or Orange. These are the scenarios I’m now preparing for. Taking a long position up to the red supply zone. High risk trade - 25% of success.
This isn’t the best setup as I prefer entering at the low of the main range, however there is a range which has formed with fully mitigated supply areas which means it has a good chance of continuing the rally rather than filling the imbalance. What I do like about it is the larger pattern (not visible as this is zoomed in - but if you move around you’ll see it)....
Technicals- A clear base has formed and there is the first higher low after a significant trendline break (green circle). There is also a bullish pattern on the 15 min within a 1hr bullish pattern where the peak of the 15 min pattern broke the final lower high of the 1hr pattern. All these are very bullish signs. Fundamentals - GlucoTrack, Inc. (GCTK) is a...
Expecting precious metals to start going up again soon. Clear 3 wave correction pattern into support on AG. Target is just shy of the all time highs. It probably coincides with $50 Silver later this year in Q3/Q4.
Anyone who is looking to go long on ETH just be a bit careful and consider this analysis as something which could play out. The first reason why I think we don’t start going up quickly again until mid-late Feb is partly due to the technical analysis showing unmitigated areas of supply / significant imbalances /FVG’s- which typically slow the market down by...
The miners are really struggling to move which isn’t usually a sign that BTC is about to make news highs. There are also patterns of weakness developing. 30% chance.
8R Trade on NIO 35% chance of success. Good opportunity to take profits at the conservative target and then can also target 9.58 as secondary more ambitious take profit
Expecting a move up to $50-60 most likely this year. Seasonal bearishness start around Oct-Nov time for precious metals so it would make sense for that to kick in around there and as I’m expecting the next move up to be the strongest since the Covid recovery move for various reasons including fundamentals and technicals - notably Platinum gearing up for wave 3...
1HR CE reaction followed by strong break of significant trendline. 30% chance of success. 7R trade. 1% risk to 7% reward.
Trade idea for the altcoin market index. If the market comes down to the buy zone by Friday or Monday next week then I see this as a valid opportunity to go long. High risk opportunity, but I think the chances are reasonable and would rate this 30% likely.
Really nice setup here on a technical basis. Larger falling wedge pattern and bullish structural shift followed by lowertime frame consolidation staying above support.
Expecting a 13R move here. Fate Therapeutics, Inc. (NASDAQ: FATE) is a clinical-stage biotechnology company specializing in induced pluripotent stem cell (iPSC) technology to develop cellular immunotherapies for cancer and immune disorders. Below are its key fundamentals: Financial Overview: Revenue: $3.1M in Q3 2024, primarily from preclinical development...